Omega-3 Fatty Acids and Their Potential Role in Parkinson’s Disease Research

This review article examines how omega-3 polyunsaturated fatty acids (n-3 PUFAs) might relate to the biology of Parkinson’s disease (PD). PD involves loss of dopamine-producing neurons, buildup of a protein called alpha-synuclein, and significant neuroinflammation and oxidative stress in the brain.

The authors summarize findings from cellular and animal studies suggesting that omega-3 fatty acids may influence several biological pathways relevant to PD, including reducing inflammatory signaling from brain immune cells (microglia), supporting astrocyte function, and helping maintain mitochondrial health and cell membrane function. The review also discusses how omega-3s appear to compete with omega-6 fatty acids, which are precursors to certain inflammatory compounds.

Importantly, this is a review of existing laboratory and animal research rather than new clinical data, and the authors note there are still significant limitations and open questions before conclusions can be drawn about use in human PD patients.